SCHEMBL293963

SCHEMBL293963

NCC(N)CC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28041693 0.97
Acetic Acid SCHEMBL724155 0.85 GRIK1 (0.33)
SCHEMBL434558 0.78
SCHEMBL23649441 0.75
SCHEMBL27393677 0.73
SCHEMBL7346167 0.73
SCHEMBL7975826 0.73
SCHEMBL4410944 0.73
SCHEMBL7819604 0.73
SCHEMBL16348518 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240059863-A1 RESIN COMPOSITION FOR SEMICONDUCTOR PACKAGE, RESIN COATED COPPER, AND CIRCUIT BOARD COMPRISING SAME LG INNOTEK CO., LTD. (KR) 2024-02-22 US disclosed
US-8906451-B2 Method for producing coated water-soluble particles CENTRAL GLASS COMPANY, LIMITED (JP) 2014-12-09 US disclosed
US-20140031334-A1 DERIVATIVES OF 4-PIPERAZIN-1-YL-4-BENZO[B]THIOPHENE SUITABLE FOR THE TREATMENT OF CNS DISORDERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2014-01-30 US disclosed
US-8598162-B2 Derivatives of 4-piperazin-1-yl-4-benzo[B]thiophene suitable for the treatment of CNS disorders OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-12-03 US disclosed
US-20120198898-A1 Method for Producing Coated Water-Soluble Particles CENTRAL GLASS COMPANY, LIMITED (JP) 2012-08-09 US disclosed
EP-2287162-B1 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of CNS disorders OTSUKA PHARMA CO LTD (JP) 2012-05-09 EP disclosed
EP-2287161-B1 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of CNS disorders OTSUKA PHARMA CO LTD (JP) 2012-05-09 EP disclosed
EP-2284169-B1 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of CNS disorders OTSUKA PHARMA CO LTD (JP) 2012-03-14 EP disclosed
US-20120028920-A1 DERIVATIVES OF 4-PIPERAZIN-1-YL-4-BENZO[B]THIOPHENE SUITABLE FOR THE TREATMENT OF CNS DISORDERS OTSUKA PHARMACEUTICAL CO., LTD. 2012-02-02 US disclosed
EP-1919907-B9 HETEROCYCLIC COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-01-18 EP disclosed
US-6176891-B1 POLYURETHANE OVERCOATING CENTRAL GLASS COMPANY, LIMITED (JP) 2001-01-23 US disclosed
EP-0956016-A1 PHARMACEUTICAL COMPOUNDS COMPRISING POLYAMINES SUBSTITUTED WITH ELECTRON-AFFINIC GROUPS Florida State University (US) 1999-11-17 EP disclosed
EP-0867422-A2 Coated granular fertilizer and method for producing same Central Glass Company, Limited (JP) 1998-09-30 EP disclosed
WO-1998014190-A9 PHARMACEUTICAL COMPOUNDS COMPRISING POLYAMINES SUBSTITUTED WITH ELECTRON-AFFINIC GROUPS 1998-07-30 WO disclosed
WO-1998014190-A1 PHARMACEUTICAL COMPOUNDS COMPRISING POLYAMINES SUBSTITUTED WITH ELECTRON-AFFINIC GROUPS FLORIDA STATE UNIVERSITY (US) 1998-04-09 WO disclosed
EP-0778333-A2 Carboxylic compositions, derivatives, lubricants, fuels and concentrates The Lubrizol Corporation (US) 1997-06-11 EP disclosed
EP-0036521-A1 Preparation of 2-imidazolines BASF Aktiengesellschaft (DE) 1981-09-30 EP disclosed
EP-0036519-A1 Process for the preparation of imidazole BASF Aktiengesellschaft (DE) 1981-09-30 EP disclosed
EP-0025191-A1 Process for the preparation of imidazoles BASF Aktiengesellschaft (DE) 1981-03-18 EP disclosed
US-4232133-A ETHYLENICALLY UNSATURATED MONOMER, POLYURETHANES ICI AMERICAS INC. (US) 1980-11-04 US disclosed